Lung cancer prediction by Deep Learning to identify benign lung nodules. (April 2021)
- Record Type:
- Journal Article
- Title:
- Lung cancer prediction by Deep Learning to identify benign lung nodules. (April 2021)
- Main Title:
- Lung cancer prediction by Deep Learning to identify benign lung nodules
- Authors:
- Heuvelmans, Marjolein A.
van Ooijen, Peter M.A.
Ather, Sarim
Silva, Carlos Francisco
Han, Daiwei
Heussel, Claus Peter
Hickes, William
Kauczor, Hans-Ulrich
Novotny, Petr
Peschl, Heiko
Rook, Mieneke
Rubtsov, Roman
von Stackelberg, Oyunbileg
Tsakok, Maria T.
Arteta, Carlos
Declerck, Jerome
Kadir, Timor
Pickup, Lyndsey
Gleeson, Fergus
Oudkerk, Matthijs - Abstract:
- Highlights: Our LCP-CNN was trained to rule out benign lung nodules with high accuracy. Excellent performance on identification of benign nodules in an external dataset (sensitivity 99 %). Malignancy could be ruled out in about 20 % of patients with 5−15 mm nodules using the LCP-CNN. Abstract: Introduction: Deep Learning has been proposed as promising tool to classify malignant nodules. Our aim was to retrospectively validate our Lung Cancer Prediction Convolutional Neural Network (LCP-CNN), which was trained on US screening data, on an independent dataset of indeterminate nodules in an European multicentre trial, to rule out benign nodules maintaining a high lung cancer sensitivity. Methods: The LCP-CNN has been trained to generate a malignancy score for each nodule using CT data from the U.S. National Lung Screening Trial (NLST), and validated on CT scans containing 2106 nodules (205 lung cancers) detected in patients from from the Early Lung Cancer Diagnosis Using Artificial Intelligence and Big Data (LUCINDA) study, recruited from three tertiary referral centers in the UK, Germany and Netherlands. We pre-defined a benign nodule rule-out test, to identify benign nodules whilst maintaining a high sensitivity, by calculating thresholds on the malignancy score that achieve at least 99 % sensitivity on the NLST data. Overall performance per validation site was evaluated using Area-Under-the-ROC-Curve analysis (AUC). Results: The overall AUC across the European centers wasHighlights: Our LCP-CNN was trained to rule out benign lung nodules with high accuracy. Excellent performance on identification of benign nodules in an external dataset (sensitivity 99 %). Malignancy could be ruled out in about 20 % of patients with 5−15 mm nodules using the LCP-CNN. Abstract: Introduction: Deep Learning has been proposed as promising tool to classify malignant nodules. Our aim was to retrospectively validate our Lung Cancer Prediction Convolutional Neural Network (LCP-CNN), which was trained on US screening data, on an independent dataset of indeterminate nodules in an European multicentre trial, to rule out benign nodules maintaining a high lung cancer sensitivity. Methods: The LCP-CNN has been trained to generate a malignancy score for each nodule using CT data from the U.S. National Lung Screening Trial (NLST), and validated on CT scans containing 2106 nodules (205 lung cancers) detected in patients from from the Early Lung Cancer Diagnosis Using Artificial Intelligence and Big Data (LUCINDA) study, recruited from three tertiary referral centers in the UK, Germany and Netherlands. We pre-defined a benign nodule rule-out test, to identify benign nodules whilst maintaining a high sensitivity, by calculating thresholds on the malignancy score that achieve at least 99 % sensitivity on the NLST data. Overall performance per validation site was evaluated using Area-Under-the-ROC-Curve analysis (AUC). Results: The overall AUC across the European centers was 94.5 % (95 %CI 92.6–96.1). With a high sensitivity of 99.0 %, malignancy could be ruled out in 22.1 % of the nodules, enabling 18.5 % of the patients to avoid follow-up scans. The two false-negative results both represented small typical carcinoids. Conclusion: The LCP-CNN, trained on participants with lung nodules from the US NLST dataset, showed excellent performance on identification of benign lung nodules in a multi-center external dataset, ruling out malignancy with high accuracy in about one fifth of the patients with 5−15 mm nodules. … (more)
- Is Part Of:
- Lung cancer. Volume 154(2021)
- Journal:
- Lung cancer
- Issue:
- Volume 154(2021)
- Issue Display:
- Volume 154, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 154
- Issue:
- 2021
- Issue Sort Value:
- 2021-0154-2021-0000
- Page Start:
- 1
- Page End:
- 4
- Publication Date:
- 2021-04
- Subjects:
- AI arteficial intelligence -- AUC area-under-the-ROC-curve analysis -- CT computed tomography -- LCP-CNN lung cancer prediction convolutional neural network -- NLST National Lung Screening Trial
Lung cancer -- Screening -- Pulmonary nodule -- Deep learning
Lungs -- Cancer -- Periodicals
Lung Neoplasms -- Abstracts
Lung Neoplasms -- Periodicals
Poumons -- Cancer -- Périodiques
Lungs -- Cancer
Periodicals
Electronic journals
Electronic journals
616.99424 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01695002 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01695002 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01695002 ↗
http://www.lungcancerjournal.info/issues ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.lungcan.2021.01.027 ↗
- Languages:
- English
- ISSNs:
- 0169-5002
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5307.245000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 16101.xml